Mutation detail:
| Mutation site | 203C>T |
| Virus | SARS-CoV-2 |
Mutation level  |
Nucleotide level |
| Gene/protein/region type | 5'UTR |
| Gene ID | - |
| Country | Iran |
| Mutation type |
- |
| Genotype/subtype/clade | - |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | NC_045512.2 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | - |
| Uniprot protein ID | - |
| Protein length | - |
| Protein description | - |
Literature information:
| Pubmed ID | 33836204 |
| Clinical information | No |
| Disease | - |
| Published year | 2021 |
| Journal | VIRUS RESEARCH |
| Title | SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses |
| Author | Mostafa Salehi-Vaziri, Mir Davood Omrani, Mohammad Hassan Pouriayevali, Fatemeh Fotouhi, Mohammad Banifazl |
| Evidence | Genomic sequence analysis of the first virus identified 11 mutated positions compared to the reference genome. The second virus, had six additional mutations from which 10 mutations were similar to the first virus including c. 241 C > T at 5'UTR, 3037 C > T in ORF1ab, NSP3, 14408 C > T in ORF1ab. NSP12, 18877 C > T inORF1ab, NSP14, 22191-3 DEL, 22444 C > T and 23403 A > G in Spike, 25563 G > T in NS3, 26735 C > T in Matrix and 28854 C > T in Nucleocapsid (Table 2). |